June 6 RxAdvocate June, 2022 — Newsletter
FDA Approves Alopecia Drug Cancer Study Results in 100% Patient Remission COVID-19 & Cardiovascular Health COVID-19 Vaccinations Authorized - Children 4 & Under RxConnection Organization Announcements...
Newsletter
June 6 RxAdvocate May, 2022 — Newsletter
CVD Prevention With Aspirin Kids Aged 4 & Under - COVID-19 Vaccines FDA Withdraws Ukoniq Approval...
May 5 RxAdvocate April, 2022 — Newsletter
Cervical Cancer Immunotherapy House Passes Bill Capping Insulin Prices FDA Approvals RxConnection Organizational Announcements...
March 3 RxAdvocate March, 2022 — Newsletter
- Purdue Pharma Comes to Opioid Settlement - USPSTF Lowers Bowel Prep Age Recommendation - Psychedelic Therapy - Additional COVID-19 Home Tests - RxConnection Organizational Announcements...
February 2 RxAdvocate February, 2022 — Newsletter
- COVID-19 Update - PrEP Treatment Guidelines - Hemophilia A - Roctavian Trial Results - Generic Revlimid Capsules Receive FDA Approval - RxConnection Organizational Announcements...
January 1 RxAdvocate January, 2022 — Newsletter
- COVID-19 At-Home Test Coverage
- COVID-19 Oral Antiviral Medication
December 12 RxAdvocate December, 2021 — Newsletter
- Biosimilar for Enbrel Blocked Until 2029
- COVID-19 Oral Antiviral Medication Coming Soon
- National Influenza Vaccination Week
November 11 RxAdvocate November, 2021 — Newsletter
- Pfizer's COVID-19 Vaccine for Kids Aged 5-11
- Eye Drops for Presbyopia
- First Interchangeable Biosimilar Insulin
November 11 RxAdvocate October, 2021 — Newsletter
- Breast Cancer Awareness - Men & Women
- Employer Covid-19 Vaccine Surcharges
- First Oral Antiviral Covid-19 Treatment Could Be Authorized
- RxConnection Organizational Announcements
September 9 RxAdvocate September, 2021 — Newsletter
- COVID Vaccine Boosters - Are They Needed?
- RSV Having Early Surge
- Recommended Diabetes Screening Start Date Changed
- RxConnection Organizational Announcements